Fumaric Acid

Fumaric Acid

SCHEMBL6406940

N=C(NNC(=O)c1cc2cc(Cl)ccc2[nH]1)c1ccccc1Cl.O=C(O)/C=C/C(=O)O

nearest known ligand 0.57

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRB1ADRB2ATP4AATP4BAXLCHRM2CHRM3DRD2FLT3HRH1HTR2AHTR2BHTR2CKCNH2KMT2AMAP2K1MAP2K2MEN1MLNRPLK4RENS1PR1SLC6A2SLC6A4atpAatpBatpCatpDatpEatpFatpFHatpGpol

The experimentally established mechanism targets of Fumaric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
MEN1 known ✓ O00255 1/20 0.48
KMT2A known ✓ Q03164 1/20 0.48
NHERF1 O14745 4/20 0.57
BCAT1 P54687 4/20 0.57
KDM4E B2RXH2 1/20 0.54
GUSB P08236 3/20 0.52
PYGL P06737 4/20 0.48
NPC1 O15118 1/20 0.48
RAB9A P51151 1/20 0.48
F7 P08709 1/20 0.47
F3 P13726 1/20 0.47
EGFR P00533 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6401150 0.94 NHERF1 (0.61) NHERF1BCAT1KDM4EGUSBPYGL
Hydrochloric Acid SCHEMBL6399705 0.92 NHERF1 (0.60) NHERF1BCAT1KDM4EGUSBPYGL
SCHEMBL6401772 0.88 BCAT1 (0.61) NHERF1BCAT1KDM4EGUSBPYGL
SCHEMBL6401177 0.87 KDM4E (0.68) NHERF1BCAT1KDM4EGUSBPYGL
SCHEMBL6406739 0.83 BCAT1 (0.62) NHERF1BCAT1KDM4EGUSBPYGL
SCHEMBL6400560 0.83 NHERF1 (0.58) NHERF1BCAT1KDM4EGUSBPYGL
SCHEMBL6399934 0.82 MEN1 (0.64) NHERF1BCAT1GUSBPYGLMEN1
Hydrochloric Acid SCHEMBL6400667 0.82 NHERF1 (0.57) NHERF1BCAT1KDM4EGUSBPYGL
SCHEMBL6404154 0.82 BCAT1 (0.53) NHERF1BCAT1KDM4EGUSBPYGL
Hydrochloric Acid SCHEMBL6400052 0.81 MEN1 (0.62) NHERF1BCAT1GUSBPYGLMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US claimed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP claimed
US-20050054696-A1 Indole compounds and medicinal use thereof JAPAN TOBACCO INC. (JP) 2005-03-10 US disclosed
EP-1452526-A1 INDOLE COMPOUND AND MEDICINAL USE THEREOF JAPAN TOBACCO INC. (JP) 2004-09-01 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050054696-A1 Indole compounds and medicinal use thereof IDO1, GPR119, SLC5A1 MEN1 1510/4885KMT2A 673/4885NHERF1 332/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.